NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2.27 Cr | ₹0.14 Cr | ₹-7.43 Cr | ₹7.18 Cr | ₹-1.46 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NGL FINECHEM ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹2.27 Cr |
| Mar2025 | ₹0.14 Cr |
| Mar2024 | ₹-7.43 Cr |
| Mar2023 | ₹7.18 Cr |
| Mar2022 | ₹-1.46 Cr |
How is Net Cash Inflow / Outflow of NGL FINECHEM Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.27 Cr | 1,535.97 | |
| Mar2025 | ₹0.14 Cr | Positive | |
| Mar2024 | ₹-7.43 Cr | Negative | |
| Mar2023 | ₹7.18 Cr | Positive | |
| Mar2022 | ₹-1.46 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,789.2 Cr | -2.5% | -11.2% | 96.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -2.5% |
-11.2% |
96.5% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses